-transparent.png){kind=logo}
Platelet monoamine oxidase (MAO) activity was significantly lower in nonpsychotic, nonorganic, unmedicated male inpatients with DSM-III-R borderline personality disorder (BPD) than in nonpsychiatric controls. Patients with BPD who also met DSM-III-R criteria for antisocial personality disorder had significantly lower MAO activity than those with BPD alone. Low MAO activity in this sample did not appear to be related to the comorbid presence of major depressive disorder or a history of substance abuse.
Related Publications
R Yehuda, and
S M Southwick, and
W S Edell, and
E L Giller
January 2017,
Current behavioral neuroscience reports,
R Yehuda, and
S M Southwick, and
W S Edell, and
E L Giller
May 1998,
Biological psychiatry,
R Yehuda, and
S M Southwick, and
W S Edell, and
E L Giller
December 1980,
Psychiatry research,
R Yehuda, and
S M Southwick, and
W S Edell, and
E L Giller
June 2007,
Psychiatric genetics,
R Yehuda, and
S M Southwick, and
W S Edell, and
E L Giller
July 1988,
Psychiatry research,
R Yehuda, and
S M Southwick, and
W S Edell, and
E L Giller
June 1980,
Biological psychiatry,
R Yehuda, and
S M Southwick, and
W S Edell, and
E L Giller
September 1987,
Psychiatry research,
R Yehuda, and
S M Southwick, and
W S Edell, and
E L Giller
November 2007,
European psychiatry : the journal of the Association of European Psychiatrists,
R Yehuda, and
S M Southwick, and
W S Edell, and
E L Giller
January 1976,
Schizophrenia bulletin,
R Yehuda, and
S M Southwick, and
W S Edell, and
E L Giller
December 1981,
Life sciences,
